COMMUNIQUÉS West-GlobeNewswire

Alphatec Announces Commercial Launch of the InVictus™ MIS and Open Spinal Fixation Systems
23/07/2019
CARLSBAD, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today [...]
Radius Health to Announce Second Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, August 7, 2019
23/07/2019
WALTHAM, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its second quarter 2019 financial results on Wednesday, August 7 th , 2019. The Company will host a [...]
CV Sciences, Inc. to Announce Second Quarter 2019 Results on August 6, 2019
23/07/2019
SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its second quarter 2019 ended June 30 [...]
Ultragenyx to Host Conference Call for Second Quarter 2019 Financial Results and Corporate Update
23/07/2019
NOVATO, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Obalon Enters Into Commercial Lease for its First Company-Owned Retail Weight Loss Center
23/07/2019
Retail site to focus exclusively on treating qualified individuals with the Obalon Balloon System SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical [...]
Diffusion Pharmaceuticals Reports Favorable Safety Data for Dose-Escalation Run-in of Phase 3 INTACT Study in Glioblastoma Multiforme Patients
23/07/2019
Data Safety Monitoring Board Recommends Continued Conduct of Study with Highest Dose of TSC CHARLOTTESVILLE, Va., July 23, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge [...]
Golden Leaf Holdings Announces Meeting of Debenture Holders
23/07/2019
TORONTO, July 23, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis company built around recognized brands for the wellness and recreational markets [...]
Spring Bank Announces Dosing of Inarigivir 400mg In Multiple HBV Studies
23/07/2019
- First Patient Dosed Ahead of Schedule in Inarigivir 400mg CATALYST 2 Trial - First Patient Completes Dosing in Inarigivir 400mg Intra-Hepatic Liver Biopsy Study - Ongoing Inarigivir + Tenofovir Alafenamide 25mg Co- [...]
Alimera Sciences Announces Multiple Papers “On Demand” at the 2019 American Society of Retina Specialists Annual Meeting
23/07/2019
ATLANTA, July 23, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors
23/07/2019
CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that Mary Szela, chief executive officer and president of TriSalus Life Sciences, has been [...]
Reflect Scientific Letter from the CEO
23/07/2019
OREM, Utah, July 23, 2019 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced an update from [...]
Vericel to Report Second-Quarter 2019 Financial Results on August 6, 2019
23/07/2019
CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence
23/07/2019
Pfizer will work with Syapse and its network of health system partners to generate insights from real-world evidence to advance cancer outcomes research SAN FRANCISCO, July 23, 2019 (GLOBE NEWSWIRE) -- Syapse, a company [...]
Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose
23/07/2019
SANTA MONICA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that it has [...]
Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call
23/07/2019
MALVERN, Pa., July 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019
23/07/2019
SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019
23/07/2019
CAMPBELL, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the second quarter of 2019 after the market close on [...]
Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer
23/07/2019
EXTON, Pa., July 23, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced the appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and the promotion of John J. Kirby to [...]
Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study
23/07/2019
Primary efficacy endpoint met with 71.2% response rate (p < 0.0001); women experienced, on average, an 84.3% reduction in menstrual blood loss (p < 0.0001) Achieved six key secondary endpoints including reduction [...]

Pages